AstraZeneca PLC ADR (AZN) Social Stream
Astrazeneca Plc (AZN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AZN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 7 | $73 | $66 | $69.1 | $66.81 | 3.43% |
| 2021-12-07 | 7 | $73 | $66 | $69.1 | $66.81 | 3.43% |
| 2022-01-17 | 7 | $73 | $60 | $67.1 | $66.81 | 0.43% |
| 2022-02-02 | 7 | $73 | $62.5 | $67.725 | $66.81 | 1.37% |
| 2022-02-10 | 7 | $69.4 | $62.5 | $65.725 | $66.81 | -1.62% |
| 2022-02-23 | 7 | $69.4 | $59.5 | $64.975 | $66.81 | -2.75% |
| 2022-02-24 | 6 | $70 | $59.5 | $66.225 | $66.81 | -0.88% |
The Trend in the Analyst Price Target
AZN's average price target has moved down $2.88 over the prior 79 days.
AZN reports an average of 14.75% for its upside potential over the past 119 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 7 | 73 | 66.0 | 69.100 | 58.80 | 17.52% |
| 2021-12-07 | 7 | 73 | 60.0 | 67.100 | 54.76 | 22.53% |
| 2022-01-21 | 7 | 73 | 62.5 | 67.725 | 59.10 | 14.59% |
| 2022-02-24 | 6 | 70 | 59.5 | 66.225 | 58.13 | 13.93% |
| 2022-02-24 | 7 | 70 | 59.5 | 66.225 | 58.13 | 13.93% |
AZN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 4 | 0 | 2 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
AZN's average broker recommendation rating improved by 0 over the prior 62 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AZN as an investment opportunity.
- In terms of how Astrazeneca Plc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 21.05% of that group.
- In the context of stocks in the large market cap category, Astrazeneca Plc's variance in analysts' estimates is lower than 42.03% of them.
- AZN has a higher number of analysts covering the stock than 106.36% of stocks in the large market cap category.
- In the context of Pharmaceutical Products stocks, Astrazeneca Plc's average analyst price target is greater than 544.87% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Astrazeneca Plc are ALNY, ALKS, and ABCL.
Make investment decisions regarding AZN using the data that counts. Try POWR Ratings for free.